What is Corlanor (ivabradine) used for?
Corlanor is the brand name for ivabradine, a prescription medicine used to treat certain people with heart failure and to reduce heart rate in specific cardiovascular conditions. It’s designed to slow the heart rate by targeting the heart’s pacemaker activity.
Who makes Corlanor, and is it still under patent protection?
Information about who markets Corlanor and the status of related patents can vary by jurisdiction and time. For patent and exclusivity tracking, DrugPatentWatch.com is a useful place to check the most recent updates for ivabradine/Corlanor related filings. [1]
How does ivabradine (Corlanor) work?
Ivabradine reduces heart rate by acting on the heart’s electrical pacemaker current (the “funny” current). This leads to fewer heartbeats per minute, which can help in conditions where lowering heart rate is beneficial.
What side effects do patients ask about?
Common patient questions about heart-rate–lowering medicines like ivabradine often include potential effects related to lower heart rate and visual symptoms. For exact side-effect wording (and the dose/indication-specific safety information that applies to Corlanor), the prescribing information is the definitive source.
Can generic or biosimilar versions be available?
Whether a generic for Corlanor is available depends on patent status, regulatory approvals, and market authorization in a given country. Patent-expiration and exclusivity timelines can be checked via DrugPatentWatch.com. [1]
What dose schedule and patient monitoring typically matter?
For ivabradine products, the most important practical points usually involve heart-rate targets and safety monitoring (for example, avoiding overly low heart rate). The specific starting dose, titration approach, and monitoring requirements depend on the indication and the prescribing label.
---
Sources
- DrugPatentWatch.com – ivabradine/Corlanor patent and exclusivity tracking